-       Report 
- February 2024
-  120 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- February 2024
-  150 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- January 2024
-  152 Pages 
- Global 
   From       €3782EUR$4,250USD£3,329GBP 
          -       Report 
- July 2024
-  132 Pages 
- Global 
   From       €845EUR$950USD£744GBP 
             The Small Molecule CMO market is a subset of the Pharmaceutical Manufacturing industry, focusing on the production of small molecule drugs. Small molecule drugs are typically composed of organic molecules, and are used to treat a variety of conditions, from cancer to cardiovascular disease. CMOs provide a range of services, from drug development and clinical trials to manufacturing and packaging. They are often used to reduce the cost and time associated with drug development, as well as to increase    the efficiency of the manufacturing process.
CMOs are typically divided into two categories: contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). CMOs focus on the production of small molecule drugs, while CDMOs provide a range of services, from drug development to manufacturing and packaging.
Companies in the Small Molecule CMO market include Boehringer Ingelheim, Catalent, Lonza, Patheon, and Recipharm. Show Less   Read more